Compare ICCM & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ICCM | MDBH |
|---|---|---|
| Founded | 2006 | 1997 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 36.7M |
| IPO Year | N/A | 2023 |
| Metric | ICCM | MDBH |
|---|---|---|
| Price | $0.61 | $3.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 250.9K | 7.4K |
| Earning Date | 11-19-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.76 |
| Revenue | ★ $2,975,000.00 | $1,250,398.00 |
| Revenue This Year | $19.87 | N/A |
| Revenue Next Year | $31.38 | N/A |
| P/E Ratio | ★ N/A | $4.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.58 | $3.11 |
| 52 Week High | $1.66 | $7.98 |
| Indicator | ICCM | MDBH |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 37.13 |
| Support Level | $0.60 | $3.18 |
| Resistance Level | $0.64 | $3.48 |
| Average True Range (ATR) | 0.03 | 0.18 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 8.92 | 11.24 |
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.